S100B protein, cerebral ultrasound and magnetic resonance imaging patterns in brain injured preterm infants

Autor: Chiara Strozzi, Giuseppe Lapergola, Bashir Moataza, Alessandro Graziosi, Marika Perrotta, Darek Gruzfeld, Milena Catenaro, Natalia Chukhlantseva, Ebe D'Adamo, Rita Salomone, Giovanni Livolti, Antonio Maconi, Caterina Di Battista, Giacomo Centini, Francesco Chiarelli, Immacolata Savarese, Hanna Aboulgar, Diego Gazzolo, Lucia Gabriella Tina, Mariangela Conte, Francesco D'Antonio, Iman Iskander, Andrea Dotta, Massimo Caulo, Francesco Nigro, Iliana Bersani, Danilo Gavilanes, Hala Mufeed, Giorgia Gasparroni, Gabriella Levantini, Adele Patrizia Primavera, Daniele Panichi, Maria Kornacka, Fabio Galvano
Přispěvatelé: RS: MHeNs - R3 - Neuroscience, RS: GROW - R4 - Reproductive and Perinatal Medicine, Kindergeneeskunde, MUMC+: MA Medische Staf Kindergeneeskunde (9)
Rok vydání: 2021
Předmět:
Zdroj: Clinical Chemistry and Laboratory Medicine, 59(9), 1527-1534. Walter de Gruyter GmbH
ISSN: 1437-4331
1434-6621
Popis: Objectives The early detection of preterm infants (PI) at risk for intraventricular hemorrhage (IVH) and neurological sequelae still constitutes an unsolved issue. We aimed at validating the role of S100B protein in the early diagnosis and prognosis of IVH in PI by means of cerebral ultrasound (CUS) and magnetic resonance imaging (MRI) today considered standard of care procedures. Methods We conducted an observational case-control study in 216 PI of whom 36 with IVH and 180 controls. Standard clinical, laboratory, radiological monitoring procedures and S100B urine measurement were performed at four time-points (first void, 24, 48, 96 h) after birth. Cerebral MRI was performed at 40–42 weeks of corrected gestational age. Results Elevated (p Conclusions The present results showing a correlation among S100B and CUS and MRI offer additional support to the inclusion of the protein in clinical daily management of cases at risk for IVH and adverse neurological outcome. The findings open the way to further investigations in PI aimed at validating new neurobiomarkers by means of S100B.
Databáze: OpenAIRE